Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder. (2022)
Attributed to:
Reducing relapse in alcohol dependence with the NMDA receptor antagonist, ketamine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1176/appi.ajp.2021.21030277
PubMed Identifier: 35012326
Publication URI: http://europepmc.org/abstract/MED/35012326
Type: Journal Article/Review
Volume: 179
Parent Publication: The American journal of psychiatry
Issue: 2
ISSN: 0002-953X